Skip to main content
. 2020 Dec 3;27(1):110–124. doi: 10.3350/cmh.2020.0125

Figure 2.

Figure 2.

Human gut microbiome was analyzed for 16s rRNA. (A) Phylum composition of normal controls and NAFLD patients with elevated liver enzymes. (B) The relative abundance of Bacteroidetes and Firmicutes. F/B ratio. (C) Composition of Lactobacillales family in normal controls and NAFLD patients. (D) Composition of Lactobacillus genus in normal controls and NAFLD patients. (E) Lactobacillus species composition. NAFLD, nonalcoholic fatty liver disease; ETC, et cetera; F/B, Firmicutes/Bacteroidetes; NS, not significant. *P<0.05. P<0.01.